Vitamin D deficiency and its role in muscle-bone interactions in the elderly

Current Osteoporosis Reports

Volumn 12, Issue 1, 2014, Pages 74-81

  Sanders, Kerrie M ^a   Scott, David ^a   Ebeling, Peter R ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Bone fractures; Elderly; Interaction; Muscle; Osteoporosis; Physical function; Review; Sarcopenia; Vitamin D deficiency

Indexed keywords

C REACTIVE PROTEIN; CALCITRIOL; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D RECEPTOR;

ADIPOGENESIS; ADIPOSE TISSUE; BONE DENSITY; BONE MARROW; BONE MINERALIZATION; CALCIUM ABSORPTION; CELL DIFFERENTIATION; FRACTURE; HUMAN; MUSCLE FUNCTION; MUSCLE MASS; MUSCLE STRENGTH; PHYSICAL PERFORMANCE; PROTEIN EXPRESSION; REVIEW; SKELETAL MUSCLE; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ACCIDENTAL FALLS; AGED; BONE DENSITY; BONE DISEASES, METABOLIC; CALCITRIOL; FRACTURES, BONE; HUMANS; MUSCLE FIBERS, FAST-TWITCH; MUSCLE STRENGTH; MUSCLE, SKELETAL; SARCOPENIA; VITAMIN D DEFICIENCY;

EID: 84895927130     PISSN: 15441873     EISSN: 15442241     Source Type: Journal    
DOI: 10.1007/s11914-014-0193-4     Document Type: Review

References (89)

1. Frost HM. Bone "mass" and the "mechanostat": a proposal. Anatomical Record. 1987;219(1):1-9.
2. Evans WJ. Skeletal muscle effects on the skeleton. In: Rosen CJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. 8th ed. USA: American Society for Bone and Mineral Research; 2013. p. 978-85.
3. Samu S, Juha S, Toni R, Risto H, Sirola J. Relationship between postmenopausal osteoporosis and the components of clinical sarcopenia. Maturitas. 2013;75(2):175-80.
4. •• Edwards MH, Gregson CL, Patel HP, Jameson KA, Harvey NC, Sayer AA, et al. Muscle size, strength and physical performance and their associations with bone structure in the Hertfordshire Cohort Study. J Bone Miner Res. 2013;28(11):2295-304. Relationship between muscle size and bone structure in older adults adds to our understanding.
5. Cooper C. The crippling consequences of fractures and their impact on quality of life. Am J Med. 1997;103(2):S12-9.
6. •• Cawthon PM, Fox KM, Gandra SR, Delmonico MJ, Chiou CF, Anthony MS, et al. Clustering of strength, physical function, muscle, and adiposity characteristics and risk of disability in older adults. J Am Geriat Soc. 2011;59(5):781-7. Clearly written, balanced evidence on muscle and adiposity characteristics.
7. Montero-Odasso M, Duque G. Vitamin D in the aging musculoskeletal system: an authentic strength preserving hormone. Molec Aspects Med. 2005;26(3):203-19. (Pubitemid 40462027)
8. Anderson PH, O'Loughlin PD, May B, Morris HA. Quantification of mRNA for the vitamin D metabolizing enzymes CYP27B1 and CYP24 and vitamin D receptor in kidney using real-time reverse transcriptase-polymerase chain reaction. J Molec Endocrinol. 2003;31(1):123-32. (Pubitemid 37063084)
9. Schubert L, DeLuca HF. Hypophosphatemia is responsible for skeletal muscle weakness of vitamin D deficiency. Arch Biochem Biophys. 2010;500(2):157-61.
10. Ceglia L, Harris SS. Vitamin D and its role in skeletal muscle. Calcified Tissue Int. 2013;92(2):151-62.
11. DeLuca HF. Historical overview of vitamin D. In: Feldman D, editor. Vitamin D, vol. 1. 3rd ed. UK: Elsevier; 2011. p. 3-12.
12. Ebeling PR, Eisman J. Vitamin D and osteoporosis. In: Feldman D, editor. Vitamin D, vol. 2. 3rd ed. UK: Elsevier; 2011. p. 1129-44.
13. Dirks-Naylor AJ, Lennon-Edwards S. The effects of vitamin D on skeletal muscle function and cellular signaling. J Steroid Biochem Mol Biol. 2011;125(3):159-68.
14. Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int. 2009;20(11):1807-20.
15. Bischoff-Ferrari HA, Dawson-Hughes B, et al. Relevance of vitamin D deficiency in adult fracture and fall prevention. In: Vitamin D, vol. 2. UK: Elsevier; 2011. p. 1145-54.
16. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, et al. Fall prevention with supplemental and active forms of vitamin D: A meta-analysis of randomized controlled trials. Br Med J. 2009;339:b3692. doi:10.1136/bmj.b3692.
17. Ebeling PR, Daly RM, Kerr DA, Kimlin MG (2013) Building healthy bones throughout life: An evidence-informed strategy to prevent osteoporosis in Australia. Med J Aust;1-9.
18. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: ameta-analysis of randomized controlled trials. JAMA. 2005;293(18):2257-64. (Pubitemid 40629192)
19. Bischoff-Ferrari HA, Willett WC, Wong JB, Stuck AE, Staehelin HB, Orav EJ, et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Int Med. 2009;169(6):551.
20. Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A. Use of calciumor calcium in combinationwith vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: A meta-analysis. Lancet. 2007;370(9588):657-66. (Pubitemid 47285316)
21. Cranney A, Weiler HA, O'Donnell S, Puil L. Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health. Am J Clin Nutrit. 2008;88(2):513S-9S.
22. Gerstenfeld LC, Zurakowski D, Schaffer JL, Nichols DP, Toma CD, Broess M, et al. Variable hormone responsiveness of osteoblast populations isolated at different stages of embryogenesis and its relationship to the osteogenic lineage. Endocrinology. 1996;137(9): 3957-68. (Pubitemid 26284672)
23. Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess. 2007;158:1-235.
24. Lips P, van Schoor NM. The effect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab. 2011;25(4): 585-91.
25. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B. Positive association between 25-hydroxy vitamin Dlevels and bone mineral density: A population-based study of younger and older adults. Am J Med. 2004;116(9):634-9. (Pubitemid 38490539)
26. Kuchuk NO, Pluijm SM, van Schoor NM, Looman CW, Smit JH, Lips P. Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metabol. 2009;94(4): 1244-50.
27. Bouillon R, Van Schoor NM, Gielen E, Boonen S, Mathieu C, Vanderschueren D, et al. Optimal vitamin D status: A critical analysis on the basis of evidence-based medicine. J Clin Endocrinol Metabol. 2013;98(8):1195.
28. Gerdhem P, Ringsberg KAM, Obrant KJ, Akesson K. Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women. Osteoporos Int. 2005;16(11):1425-31. (Pubitemid 41534648)
29. Pfeifer M, Begerow B, Minne HW, Schlotthauer T, Pospeschill M, Scholz M, et al. Vitamin D status, trunk muscle strength, body sway, falls, and fractures among 237 postmenopausal women with osteoporosis. Exp Clin Endocrinol Diabetes. 2001;109(2):87-92. (Pubitemid 32294575)
30. Michelon E, Blaum C, Semba RD, Xue Q-L, Ricks MO, Fried LP. Vitamin and carotenoid status in older women: Associations with the frailty syndrome. J Gerontol (A Biol Sci Med Sci). 2006;61(6): 600-7.
31. Shardell M, Hicks GE, Miller RR, Kritchevsky S, Andersen D, Bandinelli S, et al. Association of low vitamin D levels with the frailty syndrome in men and women. J Gerontol (A Biol Sci Med Sci). 2009;64(1):69-75.
32. Sohl E, van Schoor N, de Jongh R, Visser M, Deeg D, Lips P. Vitamin D status is associated with functional limitations and functional decline in older individuals. J Clin Endocrinol Metabol. 2013.
33. Houston DK, Tooze JA, Davis CC, Chaves PHM, Hirsch CH, Robbins JA, et al. Serum 25-hydroxyvitamin D and physical function in adults of advanced age: the CHS All Stars. J Am Geriat Soc. 2011;59(10):1793.
34. Visser M, Deeg DJH, Puts MTE, Seidell JC, Lips P. Low serum concentrations of 25-hydroxyvitamin D in older persons and the risk of nursing home admission. Am J Clin Nutrit. 2006;84(3):616-22. (Pubitemid 44713413)
35. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Hu FB, Zhang Y, Karlson EW, et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged ≥60 years. Am J Clin Nutrit. 2004;80(3):752-8. (Pubitemid 41115542)
36. Houston DK, Cesari M, Ferrucci L, Cherubini A, Maggio D, Bartali B, et al. Association between vitamin D status and physical performance: The InCHIANTI Study. J Gerontol (A Biol Sci Med Sci). 2007;62(4):440-6. (Pubitemid 47065713)
37. Tieland M, Brouwer-Brolsma E, Nienaber-Rousseau C, van Loon L, De Groot L (2013) Low vitamin D status is associated with reduced muscle mass and impaired physical performance in frail elderly people. Eur J Clin Nutrit.
38. Mowe M, Haug E, Bohmer T. Low serumcalcidiol concentration in older adults with reduced muscular function. J Am Geriat Soc. 1999;47(2):220-6. (Pubitemid 29082723)
39. Sohl E, de Jongh R, Heijboer A, Swart KMA, Brouwer-Brolsma E, Enneman A, et al. Vitamin D status is associated with physical performance: the results of three independent cohorts. Osteoporos Int. 2012;1-10.
40. Flicker L, Mead K, MacInnis RJ, Nowson C, Scherer S, Stein MS, et al. Serum vitamin D and falls in older women in residential care in Australia. J Am Geriat Soc. 2003;51(11):1533-8. (Pubitemid 37409586)
41. Snijder MB, van Schoor NM, Pluijm SMF, van Dam RM, Visser M, Lips P. Vitamin D status in relation to one-year risk of recurrent falling in older men and women. J Clin Endocrinol Metabol. 2006;91(8):2980-5. (Pubitemid 44271745)
42. Bouillon R, Verstuyf A. Vitamin D, mitochondria, and muscle. J Clin Endocrinol Metabol. 2013;98(3):961-3.
43. Prineas JW, Mason AS, Henson RA. Myopathy in metabolic bone disease. Br Med J. 1965;1(5441):1034-6.
44. Chalmers J, Conacher W, Gardner D, Scott P. Osteomalacia - a common disease in elderly women. J Bone Joint Surg Br. 1967;49(3):403-23.
45. Redzic M, Lewis RM, Thomas DT. Relationship between 25-hydoxyvitamin D, muscle strength, and incidence of injury in healthy adults: a systematic review. Nutrit Res. 2013.
46. Zamboni M, Zoico E, Tosoni P, Zivelonghi A, Bortolani A, Maggi S, et al. Relation between vitamin D, physical performance, and disability in elderly persons. J Gerontol (A Biol Sci Med Sci). 2002;57(1):7-11.
47. Janssen HC, Emmelot-Vonk MH, Verhaar HJ, van der Schouw YT. Vitamin d and muscle function: is there a threshold in the relation? JAMDA. 2013;14(8):27.
48. Visser M, Deeg DJH, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metabol. 2003;88(12):5766-72. (Pubitemid 38033048)
49. Scott D, Blizzard L, Fell J, Ding C, Winzenberg T, Jones G. A prospective study of the associations between 25-hydroxyvitamin D, sarcopenia progression, and physical activity in older adults. Clin Endocrinol. 2010;73(5):581-7.
50. • Houston DK, Tooze JA, Neiberg RH, Hausman DB, Johnson MA, Cauley JA, et al. 25-Hydroxyvitamin D status and change in physical performance and strength in older adults the health, aging, and body composition study. Am J Epidemiol. 2012;176(11):1025-34. Change in physical performance is an important aspect often missed in observational studies on vitamin D status.
51. Nowson CA, McGrath JJ, Ebeling PR, Haikerwal A, Daly RM, Sanders KM, et al. Vitamin D and health in adults in Australia and New Zealand: a position statement. Med J Aust. 2012;196(11): 686-7.
52. Lips P, Binkley N, Pfeifer M, Recker R, Samanta S, Cohn DA, et al. Once-weekly dose of 8400 IU vitamin D3 compared with placebo: effects on neuromuscular function and tolerability in older adults with vitamin D insufficiency. Am J Clin Nutrit. 2010;91(4):985.
53. Zhu K, Austin N, Devine A, Bruce D, Prince RL. A randomized controlled trial of the effects of vitamin D on muscle strength and mobility in older women with vitamin D insufficiency. J Am Geriat Soc. 2010;58(11):2063-8.
54. Lagari V, Gómez-Marín O, Levis S. The role of vitamin D in improving physical performance in the elderly. J Bone Miner Res. 2013.
55. Szulc P, Duboeuf F, Marchand F, Delmas PD. Hormonal and lifestyle determinants of appendicular skeletal muscle mass in men: the MINOS study. Am J Clin Nutrit. 2004;80(2):496-503.
56. Ceglia L, Chiu GR, Harris SS, Araujo AB. Serum 25-hydroxyvitamin D concentration and physical function in adult men. Clin Endocrinol. 2011;74(3):370-6.
57. Yoshikawa S, Nakamura T, Tanabe H, Imamura T. Osteomalacic myopathy. Endocrinologia Japonica. 1979;26(Suppl):65-72.
58. Palmucci L, Bertolotto A, Doriguzzi C, Mongini T, Coda R. Osteomalacic myopathy in a case of diffuse nodular lipomatosis of the small bowel. Acta Neurologica Belgica. 1982;82(2):65-71. (Pubitemid 12060840)
59. • Ceglia L, Niramitmahapanya S, Morais MD, Rivas DA, Harris SS, Bischoff-Ferrari H, et al. A randomized study on the effect of vitamin D3 supplementation on skeletal muscle morphology and vitamin D receptor concentration in older women. J Clin Endocrinol Metabol. 2013;9:9. Recent evidence for the role of vitamin D supplementation in muscle hypertrophy.
60. Sato Y, Iwamoto J, Kanoko T, Satoh K. Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc Dis. 2005;20(3):187-92. (Pubitemid 41254180)
61. Wang Y, DeLuca HF. Is the vitamin D receptor found in muscle? Endocrinology. 2011;152(2):354-63.
62. Simpson R, Thomas G, Arnold A. Identification of 1, 25-dihydroxyvitamin D3 receptors and activities in muscle. J Biol Chem. 1985;260(15):8882-91. (Pubitemid 15011982)
63. Bischoff-Ferrari HA, Borchers M, Gudat F, Dürmüller U, Stähelin HB, Dick W. Vitamin Dreceptor expression in humanmuscle tissue decreases with age. J Bone Miner Res. 2004;19(2):265-9. (Pubitemid 38116740)
64. Girgis CM, Clifton-Bligh RJ, Hamrick MW, Holick MF, Gunton JE. The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocrine Rev. 2013;34(1):33-83.
65. Bischoff HA, Borchers M, Gudat F, Duermueller U, Theiler R, Stähelin HB, et al. In situ detection of 1, 25-dihydroxyvitamin D receptor in human skeletal muscle tissue. Histochem J. 2001;33(1): 19-24. (Pubitemid 32368054)
66. Okuno H, Kishimoto KN, Hatori M, Itoi E. 1 α, 25-dihydroxyvitamin D3 enhances fast-myosin heavy chain expression in differentiated C2C12 myoblasts. Cell Biol Int. 2012;36(5): 441-7.
67. Ebeling P, Sandgren M, DiMagno E, Lane A, DeLuca H, Riggs B. Evidence of an age-related decrease in intestinal responsiveness to vitamin D: relationship between serum 1, 25-dihydroxyvitamin D3 and intestinal vitamin D receptor concentrations in normal women. J Clin Endocrinol Metabol. 1992;75(1):176-82.
68. Sinha A, Hollingsworth KG, Ball S, Cheetham T. Improving the vitamin D status of vitamin D deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle. J Clin Endocrinol Metabol. 2013;98(3):E509-13.
69. Scott D, Sanders KM, Ebeling PR. Vitamin D,muscle function, and falls in older adults: does reduced deposition of intramuscular adipose tissue influence the relationship? J Clin Endocrinol Metabol. 2013.
70. Visser M, Goodpaster BH, Kritchevsky SB, Newman AB, Nevitt M, Rubin SM, et al. Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J Gerontol (A Biol Sci Med Sci). 2005;60(3):324-33. (Pubitemid 40628797)
71. Marcus RL, Addison O, Dibble LE, Foreman KB, Morrell G, LaStayo P. Intramuscular adipose tissue, sarcopenia, and mobility function in older individuals. J Aging Res. 2012.
72. •• Ryan KJ, Daniel ZC, Craggs LJ, Parr T, Brameld JM. Dose-dependent effects of vitamin D on transdifferentiation of skeletal muscle cells to adipose cells. J Endocrinol. 2013;217(1):45-58. Important in the potential role of vitamin D in reducing IMAT.
73. Tagliafico AS, Ameri P, Bovio M, Puntoni M, Capaccio E, Murialdo G, et al. Relationship between fatty degeneration of thigh muscles and vitamin D status in the elderly: a preliminary MRI study. Am J Roentgenol. 2010;194(3):728-34.
74. Schellinger D, Lin CS, Hatipoglu HG, Fertikh D. Potential value of vertebral proton MR spectroscopy in determining bone weakness. Am J Neuroradiol. 2001;22(8):1620-7. (Pubitemid 32862282)
75. Bredella MA, Lin E, Gerweck AV, Landa MG, Thomas BJ, Torriani M, et al. Determinants of bone microarchitecture and mechanical properties in obese men. J Clin Endocrinol Metabol. 2012;97(11): 4115-22.
76. Duque G, Macoritto M, Kremer R. 1,25(OH)2D3 inhibits bone marrow adipogenesis in senescence accelerated mice (SAM-P/6) by decreasing the expression of peroxisome proliferator-activated receptor gamma 2 (PPARgamma2). Exp Gerontol. 2004;39(3):333-8. (Pubitemid 38264363)
77. Frost HM. Perspectives: a proposed general model of the "mechanostat" (suggestions from a new skeletal-biologic paradigm). Anatomical Record. 1996;244(2):139-47.
78. Peake JM, Kukuljan S, Nowson CA, Sanders K, Daly RM. Inflammatory cytokine responses to progressive resistance training and supplementation with fortified milk in men aged 50+ years: an 18-month randomized controlled trial. Eur J Appl Physiol. 2011;111(12):3079-88.
79. Binkley N. Is vitamin D the fountain of youth? Endocr Pract. 2009;15(6):590-6.
80. Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC study. J Gerontol (A Biol Sci Med Sci). 2002;57(5):326-32.
81. Ferrucci L, Penninx B, Volpato S, Harris TB, Bandeen-Roche K, Balfour J, et al. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriat Soc. 2002;50(12):1947-54. (Pubitemid 35462439)
82. • Peake J, Della Gatta P, Cameron-Smith D. Aging and its effects on inflammation in skeletal muscle at rest and following exercise-induced muscle injury. Am J Physiol Regul Integr Comp Physiol. 2010;298(6):14. Clearly written, adding new information in this field.
83. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutrit. 2006;83(4):754-9. (Pubitemid 44713136)
84. Van den Berghe G, Van Roosbroeck D, Vanhove P, Wouters PJ, De Pourcq L, Bouillon R. Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metabol. 2003;88(10):4623-32. (Pubitemid 37357503)
85. Phillips T, Leeuwenburgh C. Muscle fiber specific apoptosis and TNF-alpha signaling in sarcopenia are attenuated by life-long calorie restriction. FASEB J. 2005;19(6):668-70. (Pubitemid 40471280)
86. Scott W, Stevens J, Binder-Macleod SA. Human skeletal muscle fiber type classifications. Phys Ther. 2001;81(11):1810-6. (Pubitemid 33027477)
87. Roubenoff R. Sarcopenic obesity: does muscle loss cause fat gain? Lessons from rheumatoid arthritis and osteoarthritis. Ann N YAcad Sci. 2000;904:553-7. (Pubitemid 30389251)
88. Schrager M, Metter EJ, Simonsick EM, Ble A, Bandinelli S, Lauretani F, et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol. 2007;102:919-25. (Pubitemid 46377013)
89. Kim TN, Park MS, Lim KI, Choi HY, Yang SJ, Yoo HJ, et al. Relationships between sarcopenic obesity and insulin resistance, inflammation, and Vitamin D status: the Korean Sarcopenic Obesity Study (KSOS). Clin Endocrinol. 2012.